NCT05152238 ITP Registry and Accompanying Biospecimen Collection
| NCT ID | NCT05152238 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jena University Hospital |
| Condition | Immune Thrombocytopenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2021-11-29 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,100 participants in total. It began in 2021-11-29 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.
Eligibility Criteria
Inclusion Criteria: * Primary or secondary Immune Thrombocytopenia (ITP) * Age ≥18 years * signed declaration of consent Exclusion Criteria: * diagnoses that cannot be reconciled with the diagnosis of ITP (esp. heparin-induced thrombocytopenia, pregnancy-associated thrombocytopenia, pseudothrombocytopenia) * no informed consent possible (this covers patients who are unable to understand the nature and scope of participation)
Contact & Investigator
Thomas Stauch, Dr. med.
STUDY DIRECTOR
Jena University Hospital
Frequently Asked Questions
Who can join the NCT05152238 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Immune Thrombocytopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05152238 currently recruiting?
Yes, NCT05152238 is actively recruiting participants. Contact the research team at thomas.stauch@med.uni-jena.de for enrollment information.
Where is the NCT05152238 trial being conducted?
This trial is being conducted at Aachen, Germany, Altenburg, Germany, Aschaffenburg, Germany, Bad Homburg, Germany and 11 additional locations.
Who is sponsoring the NCT05152238 clinical trial?
NCT05152238 is sponsored by Jena University Hospital. The principal investigator is Thomas Stauch, Dr. med. at Jena University Hospital. The trial plans to enroll 1,100 participants.